Adverts

Open Access Articles- Top Results for Meglumine antimoniate

Meglumine antimoniate

</th></tr>
Meglumine antimoniate
File:Meglumine antimoniate major component 3D.png
Systematic (IUPAC) name
Hydroxy-dioxostiborane; (2R,3R,4R,5S)-6-methylaminohexane-1,2,3,4,5-pentol
Clinical data
AHFS/Drugs.com Micromedex Detailed Consumer Information
Identifiers
133-51-7 7pxN
P01CB01 QP51AB01
PubChem CID 64953
ChemSpider 58479 7pxY
ChEMBL CHEMBL239129 7pxY
NIAID ChemDB 008733
Chemical data
Formula Variable
Variable
 14pxN (what is this?)  (verify)

Meglumine antimoniate (or meglumine antimonate) is a medicine used for treating leishmaniasis.[1] It is manufactured by Aventis[2] and sold as Glucantime in France, and Glucantim in Italy. It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.

See also

References

  1. Soto, J.; Fuya, P.; Herrera, R.; Berman, J. (1998). "Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: Controlled study". Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 26 (1): 56–58. PMID 9455509. doi:10.1086/516267.  edit
  2. Aventis press release, 15 April 2005. Invalid language code.


Lua error in package.lua at line 80: module 'Module:Buffer' not found.